Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AAO, AB, abundant, Academy, AEs, akin, allogeneic, ALS, Amylyx, amyotrophic, Annexon, ApellisAssist, APL, Apr, Assent, AstraZeneca, Avanir, Bachem, Bermuda, Biden, biology, biometric, BioNTech, Biovitrum, blinded, border, Brazil, breathing, bribery, broker, built, CAA, Canada, category, chart, choice, coagulation, constraint, contra, contralateral, coordinated, COVID, creatinine, CRL, CUSIP, dark, DEL, Delinquent, deploy, depolarize, depth, devastating, dextromethorphan, diverge, DOJ, DSMB, EC, economy, edaravone, EEA, elderly, empowering, endorsement, EPS, equitable, exacerbated, extrafoveal, fall, fallen, fatal, fatality, FFCR, foamy, footprint, forthcoming, fovea, foveal, France, fulfill, furlough, gathered, Gemini, German, Germany, hear, heightened, hematopoietic, host, HSCT, hypothesize, identification, IgM, immunoglobin, improperly, incentivizing, intangible, Intelligent, IP, iptacopan, Irish, irrespective, Italy, ITF, Jun, junction, laid, lessen, licensor, Lineage, live, living, logistical, lung, mediated, Melbourne, membranoproliferative, MERIDIAN, MHRA, microangiopathy, microsite, missed, Mitsubishi, Moderna, molecularly, motor, movement, muscle, nationwide, native, nerve, neurodegenerative, neuroinflammation, neuromuscular, NGM, NOBLE, Nuedexta, numerator, Oct, omitted, onboarding, opted, outbreak, output, overactivation, overhaul, overturning, Paediatric, pandemic, passionate, PDCO, PDUFA, penetration, persist, persistently, Pfizer, Pharma, pharmacy, PIP, PREA, precisely, PRG, procoagulant, proinflammatory, Publ, quotient, Radicava, rank, reassessed, redirect, registry, remarkably, remotely, reopened, reorganization, rescinded, rest, riluzole, RMS, Royal, RSU, sequester, shut, shutdown, Sight, situation, Sobi, Spain, SPC, speaking, spiked, sporadic, spread, staining, sublicensable, sublicensee, sulfate, Supplementary, swallowing, Swedish, swelling, talented, Tanabe, theretofore, thickened, threat, thrombotic, tiered, Tiglutik, TMA, transplant, transplantation, transport, unaffected, uncured, undertaken, unilateral, unrealized, unwilling, upfront, urinary, usability, ventilation, Verana, virtual, virtually, vital, walking, warehousing, weekly, withheld, worker, workforce, worsening, yearly
Removed:
adjunctive, Allergan, AMP, analyzing, aplastic, apportioned, arrive, assumed, attestation, atypical, backsolve, behavior, billion, bipartisan, borrowed, brand, build, Cadillac, Carlo, Certified, classification, commenced, commensurate, comparative, computation, computed, concomitant, contemporaneously, core, curve, decided, depict, derive, designing, destroyed, earned, enzyme, exceeded, exit, formally, format, functioning, gap, guided, guideline, harmonized, hybrid, imaging, immunoglobulin, immunology, implanted, importance, Indonesia, inhaled, instilled, investigative, Jumpstart, Korea, learned, lowering, Malaysia, marketability, modeled, Monte, nondeductible, NovelMed, OPM, opsonized, outpatient, outsource, peer, poverty, predetermined, premature, pulmonology, PWERM, Ra, realizability, redeemable, reinitiated, rendered, repatriation, repriced, repricing, resumption, retentive, revising, SA, session, simplified, simplify, simulation, Singapore, South, SOX, spare, stay, streamline, streamlined, surgery, territorial, Thailand, underwriter, undistributed, unexercised, untaxed, validate, Vietnam, Zealand
Filing tables
Filing exhibits
- 10-K Annual report
- 4.4 EX-4.4 Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
- 10.17 EX-10.17
- 10.25 EX-10.25
- 10.26 EX-10.26
- 21.1 EX-21.1
- 23.1 EX-23.1
- 23.2 EX-23.2 Consent of Ey
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- 32.2 EX-32.2
- Download Excel data file
- View Excel data file
Associated APLS transcripts
APLS similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Â
We consent to the incorporation by reference in Registration Statement No. 333-235830 and 333-229091 on Form S-3 and Registration Statement No. 333-229876, 333-221528, 333-236708 and 333-236710 on Form S-8 of our reports dated February 25, 2021, relating to the financial statements of Apellis Pharmaceuticals, Inc. and its subsidiaries and the effectiveness of Apellis Pharmaceuticals, Inc. and its subsidiaries’ internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
February 25, 2021